OTC Deregulation
May 23, 2006 on 1:59 pm | In Prescribing Extra - Drugs |
Print
|
The Medicines and Healthcare products Regulatory Agency has announced the deregulation of Amorolfine and Sumatriptan.
Amorolfine is a nail lacquer licensed for the treatment of mild fungal infections of the nails. The over the counter product is called Curanail®. The Pharmaceutical Journal reports and can only be sold to patients over 18 years old with distal or lateral infection affecting up to two nails. The recommended price is £18.61.
Sumatriptan is a tablet licensed for the relief of acute migraine attacks. The over the counter product is called Imigran Recovery®. The BBC report that this product is likely to be available from mid-June at a cost of £7.99 for 2 tablets.
Action: The newly deregulated status of these products is likely to raise public interest and possibly result in increased GP consultations, especially in light of the recommended prices.
Bookmark in del.icio.us